Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study of the NovoTTF-100L(O) System (NovoTTF Therapy) (200 kHz) Concomitant With Weekly Paclitaxel for Recurrent Ovarian Carcinoma

NCT02244502 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT02244502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02244502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study of the NovoTTF-100L(O) System (NovoTTF Therapy) (200 kHz) Concomitant With Weekly Paclitaxel for Recurrent Ovarian Carcinoma
Lead sponsor
NovoCure Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
December 31, 2016
Enrollment
31 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian carcinoma